 Viridian Therapeutics, Inc. NASDAQ:VRDN Q2 2022 Earnings Conference Call August 15, 2022 8:00 AM ET Company Participants John Jordan - VP of IR Jonathan Violin - President and CEO Barrett Katz - Chief Medical Officer, Raymond Douglas - Director of Thyroid Eye Disease Kristian Humer - CFO and Chief Business Officer Conference Call Participants Chris Howerton - Jefferies Thomas Smith - SVB Securities Gavin Clark-Gartner - Evercore ISI Rami Katkhuda - LifeSci Capital Laura Chico - Wedbush Securities Kalpit Patel - B. Riley Securities FBR Jason Butler - JMP Securities Trevor Allred - Oppenheimer Michael Higgins - Ladenburg Thalmann Operator Greetings, and welcome to the Viridian Therapeutics Conference Call. 